These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1828161)

  • 21. Neuromuscular and cardiovascular effects of doxacurium in children anaesthetized with halothane.
    Goudsouzian NG; Alifimoff JK; Liu LM; Foster V; McNulty B; Savarese JJ
    Br J Anaesth; 1989 Mar; 62(3):263-8. PubMed ID: 2522789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Onset and duration of action of rocuronium in children receiving chronic anticonvulsant therapy.
    Soriano SG; Kaus SJ; Sullivan LJ; Martyn JA
    Paediatr Anaesth; 2000; 10(2):133-6. PubMed ID: 10736074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical pharmacology of doxacurium chloride. A new long-acting nondepolarizing muscle relaxant.
    Basta SJ; Savarese JJ; Ali HH; Embree PB; Schwartz AF; Rudd GD; Wastila WB
    Anesthesiology; 1988 Oct; 69(4):478-86. PubMed ID: 2972233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The clinical pharmacology of doxacurium in young adults and in elderly patients.
    Martlew RA; Harper NJ
    Anaesthesia; 1995 Sep; 50(9):779-82. PubMed ID: 7573867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rocuronium-induced neuromuscular block is affected by chronic carbamazepine therapy.
    Spacek A; Neiger FX; Krenn CG; Hoerauf K; Kress HG
    Anesthesiology; 1999 Jan; 90(1):109-12. PubMed ID: 9915319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuromuscular block with doxacurium (BW A938U) in patients with normal or absent renal function.
    Cashman JN; Luke JJ; Jones RM
    Br J Anaesth; 1990 Feb; 64(2):186-92. PubMed ID: 2138489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atracurium-induced neuromuscular block is not affected by chronic anticonvulsant therapy with carbamazepine.
    Spacek A; Neiger FX; Spiss CK; Kress HG
    Acta Anaesthesiol Scand; 1997 Nov; 41(10):1308-11. PubMed ID: 9422297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enzymatic versus pharmacologic antagonism of profound mivacurium- induced neuromuscular blockade.
    Naguib M; Selim M; Bakhamees HS; Samarkandi AH; Turkistani A
    Anesthesiology; 1996 May; 84(5):1051-9. PubMed ID: 8623998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antagonism of mivacurium-induced neuromuscular blockade in humans. Edrophonium dose requirements at threshold train-of-four count of 4.
    Kopman AF; Mallhi MU; Justo MD; Rodricks P; Neuman GG
    Anesthesiology; 1994 Dec; 81(6):1394-400. PubMed ID: 7992908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of phenytoin on the magnitude and duration of neuromuscular block following atracurium or vecuronium.
    Ornstein E; Matteo RS; Schwartz AE; Silverberg PA; Young WL; Diaz J
    Anesthesiology; 1987 Aug; 67(2):191-6. PubMed ID: 2886081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction of antibiotics on pipecuronium-induced neuromuscular blockade.
    de Gouw NE; Crul JF; Vandermeersch E; Mulier JP; van Egmond J; Van Aken H
    J Clin Anesth; 1993; 5(3):212-5. PubMed ID: 8391282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Doxacurium chloride for neuromuscular blockade before tracheal intubation and surgery during nitrous oxide-oxygen-narcotic-enflurane anesthesia.
    Lennon RL; Hosking MP; Houck PC; Rose SH; Wedel DJ; Gibson BE; Ascher JA; Rudd GD
    Anesth Analg; 1989 Mar; 68(3):255-60. PubMed ID: 2919763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dose-response relationships of doxacurium chloride in humans during anesthesia with nitrous oxide and fentanyl, enflurane, isoflurane, or halothane.
    Katz JA; Fragen RJ; Shanks CA; Dunn K; McNulty B; Rudd GD
    Anesthesiology; 1989 Mar; 70(3):432-6. PubMed ID: 2646986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Double-blind, randomized, multicenter study of doxacurium vs. pancuronium in intensive care unit patients who require neuromuscular-blocking agents.
    Murray MJ; Coursin DB; Scuderi PE; Kamath G; Prough DS; Howard DM; Abou-Donia MA
    Crit Care Med; 1995 Mar; 23(3):450-8. PubMed ID: 7874894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dose response, recovery, and cost of doxacurium as a continuous infusion in neurosurgical intensive care unit patients.
    Prielipp RC; Robinson JC; Wilson JA; MacGregor DA; Scuderi PE
    Crit Care Med; 1997 Jul; 25(7):1236-41. PubMed ID: 9233753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacodynamics of doxacurium during cardiac surgery with hypothermic cardiopulmonary bypass.
    McDonagh P; Dupuis JY; Curran M; Kitts J; Wynands JE
    Can J Anaesth; 1996 Feb; 43(2):134-40. PubMed ID: 8825538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics and pharmacodynamics of doxacurium in normal patients and in those with hepatic or renal failure.
    Cook DR; Freeman JA; Lai AA; Robertson KA; Kang Y; Stiller RL; Aggarwal S; Abou-Donia MM; Welch RM
    Anesth Analg; 1991 Feb; 72(2):145-50. PubMed ID: 1824669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuromuscular and cardiovascular effects of mivacurium chloride in surgical patients receiving nitrous oxide-narcotic or nitrous oxide-isoflurane anaesthesia.
    Choi WW; Mehta MP; Murray DJ; Sokoll MD; Forbes RB; Gergis SD; Abou-Donia M; Kirchner J
    Can J Anaesth; 1989 Nov; 36(6):641-50. PubMed ID: 2573436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cisatracurium-induced neuromuscular blockade in anticonvulsant treated neurosurgical patients.
    Koenig MH; Edwards LT
    J Neurosurg Anesthesiol; 2000 Oct; 12(4):314-8. PubMed ID: 11147379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical evaluation of doxacurium chloride.
    Maddineni VR; Cooper R; Stanley JC; Mirakhur RK; Clarke RS
    Anaesthesia; 1992 Jul; 47(7):554-7. PubMed ID: 1385680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.